Rizzo, The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction, Diabetes Metabolic Syndrome and Obesity
However, avoid combining with strong acids like retinol or AHAs initially, as this can increase irritation risk
Depression of insulin release by anti-GIP serum after oral glucose in rats
Hepatoprotective effect of silymarin
Hydration, electrolyte status, and muscle preservation strategies, including reviewing the best fiber supplements for GLP-1 users to support gut health that indirectly affects absorption, all feed into the metabolic panel picture
This combination is not FDA-approved, and no clinical trials have evaluated its safety or efficacy